In the noble quest to defeat breast cancer, TFS has been at the vanguard, making October’s Breast Cancer Awareness Month a beacon of hope and action. With a history steeped in medical innovation and patient support, we stand out among oncology CROs for our unwavering commitment to transforming the landscape of cancer care.

TFS HealthScience’s Multifaceted Engagement in Breast Cancer Awareness Month

Throughout October, we marshaled our extensive network of professionals and resources to ignite global conversations around breast cancer. From promoting early detection through self-exams and clinical screenings to participating in pink-themed fundraising activities, TFS exemplified how corporate social responsibility can make tangible impacts.

Internally, the TFS team embraced the spirit of the month, embodying a culture of care and unity. The “TFS Together” initiative became a cornerstone of this effort, fostering community engagement through charitable drives and awareness walks. Our participation in Breast Cancer Awareness Month extends beyond advocacy; it includes direct financial support to research initiatives and non-profit organizations dedicated to eradicating breast cancer.

Demonstrating Impact and Fostering Collaborations

TFS’s activities during the month were not just symbolic. At key conferences, we cleverly integrated charity into our booth activities, allowing for interactive experiences that resulted in considerable donations to breast cancer charities across Europe. Moreover, we amplified the generosity of our community through matching donation campaigns, doubling the financial support for research foundations, and extending its influence far beyond the oncology CRO industry norms. Read on to see the total funds raised from the campaign!

Our internal celebration of the “pink Fika” serves as a testament to its inclusive approach to awareness, creating a space for employees to share experiences and support the cause collectively.

A Leading Oncology & Hematology CRO

As a competitive oncology CRO, TFS has an established reputation for its strategic and operational excellence in cancer research. With over 300 studies conducted across multiple continents, we have carved a niche in early-phase trials and real-world evidence studies, particularly those involving cutting-edge treatments like cell and gene therapies.

This Breast Cancer Awareness Month, we highlight our role in spearheading clinical trials that are critical in the battle against breast cancer. Our partnership with emerging biopharma companies—constituting over 70% of the oncology pipeline—exemplifies our pivotal role in developing novel treatments. TFS’s alliance with renowned biotech firms and its representation at prestigious oncology conferences, like the SITC, further cement its status as an innovator in oncology clinical research. Learn more about our full-service oncology CRO.

Real Impact: TFS HealthScience’s Tangible Contributions to Breast Cancer Charities

In a substantial display of solidarity and commitment to breast cancer research, our initiatives during Breast Cancer Awareness Month yielded remarkable results. Our concerted efforts culminated in a significant charitable contribution, amounting to more than 1,300 Euros, benefitting several esteemed European breast cancer charities. This financial support has been directed towards organizations that are pillars in the fight against breast cancer, including Kræftens Bekæmpelse, Syöpäsäätiö, Cancerfonden, Kreftforeningen, Bröstcancerförbundet, Deutsche Krebshilfe, Cancer Research UK, and Europa Donna.

Each of these organizations plays a crucial role in advancing research, supporting patients, and educating the public about breast cancer. Our donations are poised to help these entities continue their life-saving work, reinforcing the our role as a proactive partner in the global fight against this disease.

In North America, our creative approach to fundraising married fun and philanthropy. The company hosted a virtual Halloween costume contest, with a twist of generosity. TFS pledged to donate on behalf of each employee who showcased their Halloween spirit in costume. This engaging activity not only bolstered team spirit but also translated into real-world benefits for breast cancer research.

Furthermore, the spirit of giving was matched by an anonymous benefactor, a testament to the power of collaboration and charity. This benefactor’s promise to match every dollar raised meant that each contribution had double the impact, a factor that greatly amplified the overall donation. Together, through these innovative campaigns and the generosity of supporters, TFS HealthScience and its community raised over 1,200 US Dollars for the Breast Cancer Research Foundation.

These fundraising achievements reflect TFS HealthScience’s dedication to making a difference beyond the realm of clinical research. By leveraging both fun and the universal desire to support a worthy cause, TFS has demonstrated an exemplary model of how a leading oncology CRO can extend its impact from scientific research to philanthropic success. These contributions are more than monetary; they represent hope, support, and the relentless pursuit of a cure for breast cancer.

A Future Committed to Cancer Research and Patient Support

Our dedication to breast cancer does not wane with the passing of October. It is a continual endeavor, with the “TFS Together” campaign and year-round support for cancer societies being a critical part of its identity. TFS remains a pillar of strength in the global fight against breast cancer, advancing clinical research, fostering innovations, and improving patient outcomes.

The Road Ahead: TFS HealthScience’s Continuing Legacy

As Breast Cancer Awareness Month comes to a close, our efforts serve as a robust foundation for ongoing advocacy and research. We remain poised to drive progress in the oncology CRO space, leveraging our expertise to support biotechnology and pharmaceutical sponsors dedicated to fighting the fight against breast cancer.

With our comprehensive approach to combatting breast cancer—from research and clinical trials to community involvement and corporate giving—TFS sets an industry standard for a dedicated, compassionate, and innovative ally in the enduring battle against cancer.

About TFS HealthScience

TFS HealthScience is a leading global CRO that provides clinical development and strategic resourcing solutions through a unique blend of robust operations, medical expertise, and scientific foresight. Emphasizing flexibility and a patient-centric approach, TFS partners with biotech and pharmaceutical companies to bring new therapies to market with speed and precision.